Gossamer Bio, Inc. — Director's Dealing 2019

Jun 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2019-05-30

Reporting Person: Giraudo Bryan (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-30	Common Stock	P	1000	$18.70	Acquired	1000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23879	Direct